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Abstract
Surplus goods, produced by a community, allow individuals to dedicate their efforts to abstract
problems, while enjoying the benefits of support from the community. In return, the community
benefits from the intellectual work, say, efficiently producing goods or profound medical aid. In
further elevating quality of life, we need to understand nature and biology on the most detailed
level. Inevitably, research costs are increasing along with the need for more scientists to specialize
their efforts. As a result, a vast amount of data and information is generated that needs to be
archived and made openly accessible with the permission to re-use and re-distribute. With
economies undergoing crises and prosperity in an almost cyclic manner, it seems that funding for
science and technology follows a similar pattern. Another aspect to the problem of the loss of data
is the human propensity, at the level of each individual researcher, to passively discard data in the
course of daily life and through a career. In a typical laboratory, significant amounts of information
is still stored on disks in file cabinets or on isolated computers, and is lost when a research group
disbands. Being conscientious to one's data, to see that it reaches a place in which it can persist
beyond the lifespan of any one individual requires responsibility on the part of its creator.
Editorial
What is progress? In a plain way, progress is an advance
over an existing level. To obtain a quantifiable resolution,
it is necessary to have references and contexts. References
and contexts may comprise a fair number of data and ref-
erences themselves. Where to start and what to consider?
A comprehensive answer, consequently, requires an infi-
nite amount of data and corresponding contexts. Ergo,
each datum and context must be verifiable referenced and
analyzed. Inevitably, the definition of progress requires a
well-organized archive. How much effort is directed
towards archiving? Furthermore, are enough resources
available for maintaining data and documents? How can
data that is stored in defunct formats and only accessible
by obsolete programs be viably maintained for historical
research? Is there sufficient support by and benefit for a
society associated with such an activity?
Reversing the point of view, is the stored information
appreciated and accessible? Taking it further, do we know
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what we have lost over time? Can we afford to selectively
archive what we are able to preserve for future genera-
tions? Things we may not appreciate at this moment, take
as given or consider as not suitable for in-depth investiga-
tion, are nevertheless records that could be missed at
some time in the future. Answering the basic question
from the preceding paragraph, there can never be enough
effort in preserving information.
It is now assumed, simply for the sake of the argument,
that there is no conscious selection of contents of an uni-
versal archive; access to this archive is arbitrarily set to
unrestricted. Given that the archive contains a large
number of data, one could mine this treasure for avoid-
ance of costly errors and/or synthesize existing hypotheses
to benefit existing approaches. In essence, are cultural/his-
torical/scientific lessons the true currency of an intercon-
nected society?
Conclusion
Society as a whole has to decide how much resources are
allocated towards preserving existing records, let alone the
problem of failure to extract legacy data (we suggest the
term legacy data extinction) in a technical and philo-
sophical approach. Society as a whole, research groups,
and the individual, each, has responsibility to decide how
much resources are allocated towards preserving existing
records. The problem of maintaining viable legacy data
and the challenge of the human element, each, bear on
preventing legacy data extinction to future humanity, in a
technical and philosophical approach.
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